Skip to main content

A cancer survivor fights back

April 22, 2021

UNC Lineberger’s Chad Pecot, MD — a cancer survivor himself — launched EnFuego Therapeutics with the help of UNC KickStart Venture Services to develop RNA-interference drugs that silence cancer-related gene mutations.